SUBSEQUENT EVENTS	12 Months Ended
Sep. 30, 2025
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS Subsequent to September 30, 2025, the Company: Mr. Jason May was granted 5,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Peter Rocha was granted 2,500,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Ms. Kristi Steele was granted 1,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. David Hare was granted 1,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Andrew Hamilton was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Ms. Kristine Woo was granted 10,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Anthony Leigh was granted 1,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Ilgar Isayev was granted 500,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. Mr. Steve Barnett was granted 250,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. On October 22, 2025, the Company entered into a Promissory Loan Note with Parallel40 LLC, in the amount of $50,000, with a maturity date of October 22, 2027. The loan will accrue interest at the rate of 10% per annum. The Company issued 5,000,000 shares, per the terms of the agreement. On October 22, 2025, the Company entered into a Promissory Loan Note with Corbin Hare, in the amount of $50,000, with a maturity date of October 22, 2027. The loan will accrue interest at the rate of 10% per annum. The Company issued 5,000,000 shares, per the terms of the agreement. On October 22, 2025, Parallel40 LLC was approved to receive 8,000,000 shares as compensation for fundraising services. As of this filing date, the shares have been approved but remain unissued. On November 19, 2025, Sativus Investments entered into a debt-to-equity agreement with the Company. Pursuant to the terms of the agreement, the Company is obligated to issue 43,000,000 shares. As of this filing date, the shares remain unissued. Stuart Allen was granted 500,000 shares, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued. The Company has evaluated events occurring subsequent to September 30, 2025 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

SUBSEQUENT EVENTS

12 Months Ended

Sep. 30, 2025

NOTE 14 – SUBSEQUENT EVENTS

Subsequent to September 30, 2025, the Company:

Mr. Jason May was granted 5,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Peter Rocha was granted 2,500,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristi Steele was granted 1,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. David Hare was granted 1,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Andrew Hamilton was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristine Woo was granted 10,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Anthony Leigh was granted 1,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Ilgar Isayev was granted 500,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Steve Barnett was granted 250,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

On October 22, 2025, the Company entered into a Promissory Loan Note with Parallel40 LLC, in the amount of $50,000, with a maturity date of October 22, 2027. The loan will accrue interest at the rate of 10% per annum. The Company issued 5,000,000 shares, per the terms of the agreement.

On October 22, 2025, the Company entered into a Promissory Loan Note with Corbin Hare, in the amount of $50,000, with a maturity date of October 22, 2027. The loan will accrue interest at the rate of 10% per annum. The Company issued 5,000,000 shares, per the terms of the agreement.

On October 22, 2025, Parallel40 LLC was approved to receive 8,000,000 shares as compensation for fundraising services. As of this filing date, the shares have been approved but remain unissued.

On November 19, 2025, Sativus Investments entered into a debt-to-equity agreement with the Company. Pursuant to the terms of the agreement, the Company is obligated to issue 43,000,000 shares. As of this filing date, the shares remain unissued.

Stuart Allen was granted 500,000 shares, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

The Company has evaluated events occurring subsequent to September 30, 2025 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

Graphene & Solar Technologies Ltd 10-K